SVACF / SciVac Therapeutics Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

SciVac Therapeutics Inc.
US ˙ OTC
이 기호는 더 이상 활성화되지 않습니다.

내부자 지분3,290,496 shares
내부자 센티멘트 점수

내부자 센티멘트 점수를 통해서 내부자들이 법인 지분을 매입하는 기업들에 대해서 알아볼 수 있습니다.

이는 내부자의 누적도가 가장 높은 기업을 식별하는 정교하고 복합적인 지수를 분석하는 계량 모델의 결과 값입니다. 스코어링 모델은 이전 90일 동안 매수한 "내부자의 순 숫자", "매수한 주식의 총합", "내부자가 소유한 주식의 총합"의 조합을 사용합니다. 점수는 0에서 100 사이이며, 점수가 높을수록 피어(Peer: 동종업계 경쟁기업)에 대한 누적도가 높다는 것을 나타내며, 평균은 50입니다.

업데이트 주기: 일별

내부자의 누적도가 가장 높은 기업 목록을 확인할 수 있는 내부자들의 최다 선택(Insiders Top Picks)을 참고하십시오.

내부 경영진 센티멘트 점수

내부 경영진 센티멘트 점수를 통해서 내부 경영진들이 법인 지분을 매입하는 기업들에 대해서 알아볼 수 있습니다.

내부 거래의 정의에 따라 내부 경영진(기업 임원)도 내부자이지만, 다른 내부자(10% 주주 및 이사회 구성원)들과는 달리 내부 경영진은 매일 회사에서 근무하며, 거래 시에 자신의 자금을 사용합니다. (많은 경우에 10% 주주 및 이사회 구성원은 다른 사람의 자금을 관리하는 자금 관리자입니다.) 따라서 내부 경영진(기업 임원: Officer)의 내부 거래는 훨씬 더 중요하며 올바른 분석이 필요합니다.

내부자 센티멘트 점수와 마찬가지로 임원 감정 점수는 가장 높은 수준의 임원 축적을 가진 기업을 식별하는 정교하고 복합적인 지수 퀀트(Multi-factor quantitative) 모델의 결과입니다.

업데이트 주기: 일별

내부자의 누적도가 가장 높은 기업 목록을 확인할 수 있는 내부자들의 최다 선택(Insiders Top Picks)을 참고하십시오.

주요 내부자 지표

이 수치는 해당 기업이 다양한 내부자 지표에 따라 어떻게 순위를 매겨지는 지를 설명합니다. 백분위 순위는 이 기업이 미국 시장의 다른 기업들과 어떻게 비교되는지 보여줍니다. 순위가 높을수록 더 나은 상황에 있다는 것을 의미합니다.

예를 들어, 일반적으로 내부자의 매입은 긍정적인 지표라고 간주되어지기 때문에, 내부자의 매입(내부자의 매각, 역시도)가 적은 기업보다 내부자의 매입이 많은 기업은 순위가 높을 것입니다.

내부자의 순 매입(순위)

N/A

내부자의 순 매입(Net Number of Insiders Buying)는 내부자 매수의 총 수에서 지난 90일 동안의 내부자 매도의 총 수를 뺀 값입니다. 여기에 백분위 순위가 표시됩니다(범위: 0~100%).

내부자가 매입한 플로트 비율 (순위)

N/A

"내부자가 매입한 플로트 비율(Percent of Float Bought by Insiders)"은 내부자가 매입한 주식의 총 수에서 내부자가 매도한 주식의 총 수를 뺀 값을 전체 플로트로 나눈 값에 100을 곱한 값입니다. * ((내부자가 매입한 주식의 총 수 - 내부자가 매도한 주식의 총 수) ÷ 전체 플로트) x 100

내부자 트레이딩 차트

SciVac Therapeutics Inc. 내부자의 매매 거래는 아래 차트에 나와 있습니다. 내부자들은 기업의 임원(내부 경영진), 이사 또는 주요 투자자입니다. 일반적으로 내부자가 중요한 비공개 정보를 기반으로 자신이 속한 기업을 거래하는 것은 불법으로 간주됩니다. 이것은 내부자가 자신의 기업 내에서 행하는 모든 거래가 불법이라는 것을 뜻은 아닙니다. 그러나 그들은 자신들의 모든 거래를 양식 4를 통해 SEC에 보고해야만 합니다.

내부자의 명단 및 이익 지표

아래 표는 공개된 내부자의 목록이며, SEC에 공개된 제출 문서에서 자동으로 생성됩니다. "이름", "가장 최근의 직급", "이사, 임원 또는 10% 주주"에 대한 지정 외에도 최근에 공개된 보유 주식에 대한 정보를 보여줍니다. 또한 가능한 경우 내부자의 과거 거래 실적도 확인 가능합니다. 과거 거래 실적은 내부자가 실제 "공개 시장"(Open market) 매입 거래를 수행한 실적을 가중 평균한 값입니다. 이 계산 방법에 대한 자세한 내용은 유튜브 웨비나 를 참조하시면 됩니다.

See our leaderboard of most profitable insider traders.

내부자 평균 이익률 (%) 소유
지분
주식
분할

Report errors via our new Insider Auditing Tool

내부자의 매입 내역 추적: 단기 이익 분석

이 섹션에서는 SVACF / SciVac Therapeutics Inc.에서 계획되지 않은 "공개 시장"(Open market)의 내부자가 매입한 모든 상품의 수익성을 분석합니다. 이 분석을 통해서 내부자가 비정상적인 수익을 지속적으로 창출하는지 파악하는 데 도움이 되며, 이러한 분석은 수행해볼 가치가 있습니다. 이 분석은 개별 거래 후 1년 동안 수행한 것이며, 결과는 이론 값입니다. .

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 "공개 시장"(Open market)에서의 매입을 보여줍니다.

거래일 내부자 보고된
지분
보고된
가격
조정된
지분
조정된
가격
가격 기준 최고까지
일수
최고에서
가격
최고
이익 ($)
최고 수익률 (%)
2023-07-10 GILLIS STEVEN 609,090 1.6500 609,090 1.6500 1,004,998 9 1.5000 -91,363 -9.09
2021-12-03 Beattie Nell 8,200 2.4492 273 73.4760 20,083
2020-04-24 PERCEPTIVE ADVISORS LLC 9,090,909 1.1000 303,030 33.0000 10,000,000
2019-10-04 Diaz-Mitoma Francisco 40,000 0.5000 1,333 15.0000 20,000
2019-10-01 McNulty Christopher 12,000 0.4730 400 14.1900 5,676
2019-10-01 Beattie Nell 10,000 0.4822 333 14.4660 4,822
2019-09-30 Baxter Jeff 150,000 0.5030 5,000 15.0900 75,450
2019-09-30 Diaz-Mitoma Francisco 14,500 0.5000 483 15.0000 7,250
2019-09-23 PERCEPTIVE ADVISORS LLC 20,000,000 0.5000 666,667 15.0000 10,000,000

조정된 가격은 분할 조정 가격입니다. 조정된 지분은 분할 조정 지분입니다.

SVACF / SciVac Therapeutics Inc. Insider Trades
내부자 매매의 실적: 단기 손실 분석

이 섹선에서는 SVACF / SciVac Therapeutics Inc.에서 이루어진 "공개 시장(Open market)"에서의 모든 계획되지 않은 내부자 매매의 단기 손실 회피(Short-term loss avoidance)를 분석합니다. 일관된 손실 회피 패턴을 통해서 향후 매매 거래가 가격 하락을 초래할 수도 있음을 예상할 수 있습니다. 이 분석은 각 각 매매 거래 후 1년 동안의 자료이며, 결과는 이론 값입니다. .

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 공개 시장에서의 매매를 보여줍니다.

거래일 내부자 보고된
지분
보고된
가격
조정된
지분
조정된
가격
가격 기준 최저까지
일수
최저에서
가격
회피된
최대 손실($)
회피된
최대 손실율(%)
2023-04-06 PERCEPTIVE ADVISORS LLC 4,251,563 0.1100 141,719 3.3000 467,672 202 0.4960 -397,379 -84.97
2023-04-05 PERCEPTIVE ADVISORS LLC 1,832,563 0.1300 61,085 3.9000 238,233
2023-04-04 PERCEPTIVE ADVISORS LLC 4,810,623 0.1600 160,354 4.8000 769,700
2021-12-01 PERCEPTIVE ADVISORS LLC 2,707,463 3.3100 90,249 99.3000 8,961,703
2021-06-29 PERCEPTIVE ADVISORS LLC 500,709 3.8000 16,690 114.0000 1,902,694
2021-06-29 PERCEPTIVE ADVISORS LLC 145,548 3.8000 4,852 114.0000 553,082
2021-06-09 PERCEPTIVE ADVISORS LLC 1,102,179 4.0000 36,739 120.0000 4,408,716
2021-06-09 PERCEPTIVE ADVISORS LLC 320,388 4.0000 10,680 120.0000 1,281,552

조정된 가격은 분할 조정 가격입니다. 조정된 지분은 분할 조정 지분입니다.

SVACF / SciVac Therapeutics Inc. Insider Trades
거래 내역

전체 거래 내역을 보려면 링크 아이콘을 클릭하세요. 10b5-1 자동 거래 계획의 일부로 보고된 거래는 10b-5 열에 X 표시가 나타납니다.

보고일 거래일 양식 내부자 티커 증권 소유권 코드 10b5-1 직접 행사
가격
단위
가격
단위
변동
가치
변동 (단위: 1,000)
잔여
옵션
잔여
주식
2023-07-18 2023-07-10 4 GILLIS STEVEN See Footnotes VBIV Common Shares, no par value per share P - Purchase I 1.6500 609,090 1,005 1,043,292
2023-04-06 2023-04-06 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock S - Sale I 0.1100 -4,251,563 -468 41,440,729
2023-04-06 2023-04-05 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock S - Sale I 0.1300 -1,832,563 -238 45,691,816
2023-04-06 2023-04-04 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock S - Sale I 0.1600 -4,810,623 -770 47,524,379
2022-01-31 2022-01-27 4 DeWilde Michel VBIV Option (Right to Buy Common Shares) A - Award D 1.53 75,000 75,000
2022-01-31 2022-01-27 4 McNulty Christopher VBIV Option (Right to Buy Common Shares) A - Award D 1.53 400,000 400,000
2022-01-31 2022-01-27 4 McKee Blaine H. VBIV Option (Right to Buy Common Shares) A - Award D 1.53 75,000 75,000
2022-01-31 2022-01-27 4 Mazaltov Avi VBIV Option (Right to Buy Common Shares) A - Award D 1.53 400,000 400,000
2022-01-31 2022-01-27 4 GILLIS STEVEN VBIV Option (Right to Buy Common Shares) A - Award D 1.53 100,000 100,000
2022-01-31 2022-01-27 4 Diaz-Mitoma Francisco VBIV Option (Right to Buy Common Shares) A - Award D 1.53 400,000 400,000
2022-01-31 2022-01-27 4 Cordeiro Joanne VBIV Option (Right to Buy Common Shares) A - Award D 1.53 75,000 75,000
2022-01-31 2022-01-27 4 Braga Damian VBIV Option (Right to Buy Common Shares) A - Award D 1.53 75,000 75,000
2022-01-31 2022-01-27 4 Beattie Nell VBIV Option (Right to Buy Common Shares) A - Award D 1.53 400,000 400,000
2022-01-31 2022-01-27 4 Baxter Jeff VBIV Option (Right to Buy Common Shares) A - Award D 1.53 800,000 800,000
2022-01-31 2022-01-27 4 Bain Linda VBIV Option (Right to Buy Common Shares) A - Award D 1.53 75,000 75,000
2022-01-31 2022-01-27 4 Anderson David Evander VBIV Option (Right to Buy Common Shares) A - Award D 1.53 400,000 400,000
2021-12-06 2021-12-03 4 Beattie Nell VBIV Common Shares, no par value per share P - Purchase D 2.4492 8,200 20 68,200
2021-12-03 2021-12-01 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock S - Sale I 3.3100 -2,707,463 -8,962 52,334,993
2021-07-07 2021-07-01 4 Bain Linda VBIV Option (Right to Buy Common Shares) A - Award D 3.43 250,000 250,000
2021-06-30 2021-06-29 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock S - Sale I 3.8000 -145,548 -553 0
2021-06-30 2021-06-29 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock S - Sale I 3.8000 -500,709 -1,903 0
2021-06-11 2021-06-09 4 PERCEPTIVE ADVISORS LLC VBIV Warrant (right to buy) X - Other I 2.75 -465,936 0
2021-06-11 2021-06-09 4 PERCEPTIVE ADVISORS LLC VBIV Warrant (right to buy) X - Other I 2.75 -1,602,888 0
2021-06-11 2021-06-09 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock S - Sale I 4.0000 -320,388 -1,282 145,548
2021-06-11 2021-06-09 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock S - Sale I 4.0000 -1,102,179 -4,409 500,709
2021-06-11 2021-06-09 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock X - Other I 2.7500 465,936 1,281 465,936
2021-06-11 2021-06-09 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock X - Other I 2.7500 1,602,888 4,408 1,602,888
2021-02-01 2021-01-27 4 DeWilde Michel VBIV Option (Right to Buy Common Shares) A - Award D 3.15 75,000 75,000
2021-02-01 2021-01-27 4 Mazaltov Avi VBIV Option (Right to Buy Common Shares) A - Award D 3.14 500,000 500,000
2021-01-29 2021-01-27 4 McKee Blaine H. VBIV Option (Right to Buy Common Shares) A - Award D 3.15 75,000 75,000
2021-01-29 2021-01-27 4 Diaz-Mitoma Francisco VBIV Option (Right to Buy Common Shares) A - Award D 3.14 500,000 500,000
2021-01-29 2021-01-27 4 Braga Damian VBIV Option (Right to Buy Common Shares) A - Award D 3.15 75,000 75,000
2021-01-29 2021-01-27 4 Beattie Nell VBIV Option (Right to Buy Common Shares) A - Award D 3.15 500,000 500,000
2021-01-29 2021-01-27 4 Cordeiro Joanne VBIV Option (Right to Buy Common Shares) A - Award D 3.15 75,000 75,000
2021-01-29 2021-01-27 4 McNulty Christopher VBIV Option (Right to Buy Common Shares) A - Award D 3.15 500,000 500,000
2021-01-29 2021-01-27 4 Anderson David Evander VBIV Option (Right to Buy Common Shares) A - Award D 3.15 500,000 500,000
2021-01-29 2021-01-27 4 GILLIS STEVEN VBIV Option (Right to Buy Common Shares) A - Award D 3.15 100,000 100,000
2021-01-29 2021-01-27 4 Baxter Jeff VBIV Option (Right to Buy Common Shares) A - Award D 3.15 1,000,000 1,000,000
2020-07-02 2020-07-01 4 Baxter Jeff VBIV Option (Right to Buy Common Shares) A - Award D 2.94 425,200 425,200
2020-07-02 2020-07-01 4 Diaz-Mitoma Francisco VBIV Option (Right to Buy Common Shares) A - Award D 2.99 167,150 167,150
2020-07-02 2020-07-01 4 Mazaltov Avi VBIV Option (Right to Buy Common Shares) A - Award D 2.99 167,150 167,150
2020-07-02 2020-07-01 4 McNulty Christopher VBIV Option (Right to Buy Common Shares) A - Award D 2.94 170,100 170,100
2020-07-02 2020-07-01 4 Beattie Nell VBIV Option (Right to Buy Common Shares) A - Award D 2.94 170,100 170,100
2020-07-02 2020-07-01 4 Anderson David Evander VBIV Option (Right to Buy Common Shares) A - Award D 2.94 170,100 170,100
2020-04-28 2020-04-24 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock P - Purchase I 1.1000 9,090,909 10,000 55,042,456
2020-03-24 2020-03-24 4 Braga Damian VBIV Option (Right to Buy Common Shares) A - Award D 0.81 250,000 250,000
2020-01-24 2020-01-22 4 McKee Blaine H. VBIV Option (Right to Buy Common Shares) A - Award D 1.46 250,000 250,000
2020-01-24 2020-01-22 4 GILLIS STEVEN VBIV Option (Right to Buy Common Shares) A - Award D 1.46 350,000 350,000
2020-01-24 2020-01-22 4 McNulty Christopher VBIV Option (Right to Buy Common Shares) A - Award D 1.46 350,000 350,000
2020-01-24 2020-01-22 4 Beattie Nell VBIV Option (Right to Buy Common Shares) A - Award D 1.46 350,000 350,000
2020-01-24 2020-01-22 4 Cordeiro Joanne VBIV Option (Right to Buy Common Shares) A - Award D 1.46 250,000 250,000
2020-01-24 2020-01-22 4 Diaz-Mitoma Francisco VBIV Option (Right to Buy Common Shares) A - Award D 1.66 350,000 350,000
2020-01-24 2020-01-22 4 Anderson David Evander VBIV Option (Right to Buy Common Shares) A - Award D 1.46 350,000 350,000
2020-01-24 2020-01-22 4 Mazaltov Avi VBIV Restricted Stock Units A - Award D 50,000 50,000
2020-01-24 2020-01-22 4 DeWilde Michel VBIV Option (Right to Buy Common Shares) A - Award D 1.46 250,000 250,000
2020-01-24 2020-01-22 4 Baxter Jeff VBIV Option (Right to Buy Common Shares) A - Award D 1.46 500,000 500,000
2019-10-07 2019-10-04 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share P - Purchase I 0.5000 40,000 20 117,500
2019-10-07 2019-09-30 4 Diaz-Mitoma Francisco By wife VBIV Common Shares, no par value per share P - Purchase I 0.5000 14,500 7 14,500
2019-10-01 2019-10-01 4 Beattie Nell VBIV Common Shares, no par value per share P - Purchase D 0.4822 10,000 5 60,000
2019-10-01 2019-10-01 4 McNulty Christopher VBIV Common Shares, no par value per share P - Purchase D 0.4730 12,000 6 37,000
2019-09-30 2019-09-30 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 0.5030 150,000 75 608,255
2019-09-24 2019-09-23 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock P - Purchase I 0.5000 20,000,000 10,000 45,951,556
2019-07-01 2019-06-27 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share P - Purchase I 1.0700 8,000 9 77,500
2019-06-20 2019-06-20 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share P - Purchase I 0.8900 42,000 37 69,500
2019-06-20 2019-06-20 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share P - Purchase I 0.7800 10,000 8 27,500
2019-06-20 2019-06-18 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock P - Purchase I 0.6500 1,000,000 650 25,951,556
2019-06-19 2019-06-19 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 0.7315 144,000 105 458,255
2019-06-19 2019-06-19 4 Beattie Nell VBIV Common Shares, no par value per share P - Purchase D 0.7357 8,000 6 50,000
2019-06-18 2019-06-14 4 GILLIS STEVEN VBIV Restricted Stock Units (RSUs) M - Exercise D -18,750 0
2019-06-18 2019-06-14 4 GILLIS STEVEN VBIV Common Shares, no par value per share M - Exercise D 18,750 84,416
2019-06-18 2019-06-14 4 Baxter Jeff VBIV Restricted Stock Units (RSUs) M - Exercise D -31,250 0
2019-06-18 2019-06-14 4 Baxter Jeff VBIV Common Shares, no par value per share M - Exercise D 31,250 314,255
2019-06-18 2019-06-14 4 Beattie Nell VBIV Restricted Stock Units (RSUs) M - Exercise D -6,250 0
2019-06-18 2019-06-14 4 Beattie Nell VBIV Common Shares, no par value per share M - Exercise D 6,250 42,000
2019-06-18 2019-06-14 4 DeWilde Michel VBIV Restricted Stock Units (RSUs) M - Exercise D -12,500 0
2019-06-18 2019-06-14 4 DeWilde Michel VBIV Common Shares, no par value per share M - Exercise D 12,500 50,000
2019-06-18 2019-06-14 4 Anderson David Evander VBIV Restricted Stock Units (RSUs) M - Exercise D -21,875 0
2019-06-18 2019-06-14 4 Anderson David Evander VBIV Common Shares, no par value per share M - Exercise D 21,875 148,209
2019-06-18 2019-06-17 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock P - Purchase I 0.6180 1,000,000 618 24,951,556
2019-04-24 2019-04-18 4 Cordeiro Joanne VBIV Option (Right to Buy Common Shares) A - Award D 1.97 200,000 200,000
2019-02-04 2019-01-31 4 Beattie Nell VBIV Option (Right to Buy Common Shares) A - Award D 1.67 300,000 300,000
2019-02-04 2019-01-31 4 Beattie Nell VBIV Common Shares, no par value per share A - Award D 15,000 35,750
2019-02-04 2019-01-31 4 Anderson David Evander VBIV Option (Right to Buy Common Shares) A - Award D 1.67 300,000 300,000
2019-02-04 2019-01-31 4 Anderson David Evander VBIV Common Shares, no par value per share A - Award D 25,000 126,334
2019-02-04 2019-01-31 4 Mazaltov Avi VBIV Common Share A - Award D 90,000 196,000
2019-02-04 2019-01-31 4 Requadt Scott VBIV Option (Right to Buy Common Shares) A - Award D 1.67 200,000 200,000
2019-02-04 2019-01-31 4 McNulty Christopher VBIV Option (Right to Buy Common Shares) A - Award D 1.67 300,000 300,000
2019-02-04 2019-01-31 4 McNulty Christopher VBIV Common Shares, no par value per share A - Award D 25,000 25,000
2019-02-04 2019-01-31 4 DeWilde Michel VBIV Option (Right to Buy Common Shares) A - Award D 1.67 200,000 200,000
2019-02-04 2019-01-31 4 Baxter Jeff VBIV Option (Right to Buy Common Shares) A - Award D 1.67 450,000 450,000
2019-02-04 2019-01-31 4 Baxter Jeff VBIV Common Shares, no par value per share A - Award D 50,000 283,005
2019-02-04 2019-01-31 4 Diaz-Mitoma Francisco VBIV Option (Right to Buy Common Shares) A - Award D 1.64 300,000 300,000
2019-02-04 2019-01-31 4 GILLIS STEVEN VBIV Option (Right to Buy Common Shares) A - Award D 1.67 300,000 300,000
2019-02-04 2019-01-31 4 McKee Blaine H. VBIV Option (Right to Buy Common Shares) A - Award D 1.67 300,000 300,000
2019-02-04 2019-01-31 4 Kariv Tomer VBIV Option (Right to Buy Common Shares) A - Award D 1.64 200,000 200,000
2018-12-18 2018-12-17 4 Kariv Tomer By Pontifax Late Stage Fund L.P. VBIV Common Stock P - Purchase I 1.4000 185,714 260 185,714
2018-12-18 2018-12-17 4 Kariv Tomer By Pontifax (China) IV Limited Partnership VBIV Common Stock P - Purchase I 1.4000 331,429 464 943,451
2018-12-18 2018-12-17 4 Kariv Tomer By Pontifax (Cayman) IV Limited Partnership VBIV Common Stock P - Purchase I 1.4000 298,431 418 849,520
2018-12-18 2018-12-17 4 Kariv Tomer By Pontifax (Israel) IV Limited Partnership VBIV Common Stock P - Purchase I 1.4000 612,997 858 1,744,969
2018-12-17 2018-12-13 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock P - Purchase I 1.4000 14,285,714 20,000 23,631,439
2018-09-21 2018-09-19 4 McNulty Christopher VBIV Option (Right to Buy Common Shares) A - Award D 1.83 250,000 250,000
2018-08-07 2018-08-06 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 1.9268 8,100 16 233,005
2018-08-06 2018-08-03 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share P - Purchase I 2.1000 6,000 13 17,500
2018-08-06 2018-08-02 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share P - Purchase I 2.2000 3,000 7 11,500
2018-08-06 2018-08-03 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 2.0082 13,500 27 224,905
2018-08-03 2018-08-03 4 Beattie Nell VBIV Common Shares, no par value per share P - Purchase D 2.0057 2,000 4 20,750
2018-08-01 2018-07-31 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 2.2760 16,800 38 211,405
2018-07-03 2018-06-14 4/A Anderson David Evander VBIV Common Shares, no par value per share F - Taxes D 3.7600 -9,281 -35 101,334
2018-06-29 2018-01-23 4/A Mazaltov Avi VBIV Option (Right to Buy Common Shares) A - Award D 4.19 0 0
2018-06-29 2018-01-23 4/A Mazaltov Avi VBIV Common Share A - Award D 100,000 106,000
2018-06-25 2018-06-14 4 GILLIS STEVEN VBIV Restricted Stock Units (RSUs) M - Exercise D -18,750 18,750
2018-06-25 2018-06-14 4 GILLIS STEVEN VBIV Common Shares, no par value per share M - Exercise D 18,750 65,666
2018-06-20 2018-06-14 4 DeWilde Michel VBIV Restricted Stock Units (RSUs) M - Exercise D -12,500 12,500
2018-06-20 2018-06-14 4 DeWilde Michel VBIV Common Shares, no par value per share M - Exercise D 12,500 37,500
2018-06-18 2018-06-14 4 Requadt Scott VBIV Restricted Stock Units (RSUs) M - Exercise D -12,500 12,500
2018-06-18 2018-06-14 4 Requadt Scott VBIV Common Shares, no par value per share M - Exercise D 12,500 37,500
2018-06-18 2018-06-14 4 Rubin Steven D VBIV Restricted Stock Units (RSUs) M - Exercise D -18,750 18,750
2018-06-18 2018-06-14 4 Rubin Steven D VBIV Common Shares, no par value per share M - Exercise D 18,750 56,250
2018-06-18 2018-06-14 4 Baxter Jeff VBIV Restricted Stock Units (RSUs) M - Exercise D -31,250 31,250
2018-06-18 2018-06-14 4 Baxter Jeff VBIV Common Shares, no par value per share M - Exercise D 31,250 194,605
2018-06-18 2018-06-14 4 Beattie Nell VBIV Restricted Stock Units (RSUs) M - Exercise D -6,250 6,250
2018-06-18 2018-06-14 4 Beattie Nell VBIV Common Shares, no par value per share M - Exercise D 6,250 18,750
2018-06-18 2018-06-14 4 Anderson David Evander VBIV Restricted Stock Units (RSUs) M - Exercise D -21,875 21,875
2018-06-18 2018-06-14 4 Anderson David Evander VBIV Common Shares, no par value per share F - Taxes D 3.7600 -9,306 -35 101,309
2018-06-18 2018-06-14 4 Anderson David Evander VBIV Common Shares, no par value per share M - Exercise D 21,875 110,615
2018-06-18 2018-06-14 4 Logal Adam VBIV Restricted Stock Units (RSUs) M - Exercise D -12,500 12,500
2018-06-18 2018-06-14 4 Logal Adam VBIV Common Shares, no par value per share M - Exercise D 12,500 37,500
2018-05-25 2018-05-24 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 2.9900 11,000 33 163,355
2018-05-14 2018-05-11 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 2.9100 7,100 21 152,355
2018-05-14 2018-05-11 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value P - Purchase D 3.1300 4,500 14 268,839
2018-05-14 2018-05-11 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value P - Purchase I 2.9800 5,500 16 8,500
2018-02-06 2018-01-23 4 Kartsaklis Athena VBIV Option (Right to Buy Common Shares) A - Award D 4.26 75,000 75,000
2018-01-30 3 Mazaltov Avi VBIV Common Shares, no par value per share D 12,000
2018-01-30 3 Mazaltov Avi VBIV Common Shares, no par value per share D 12,000
2018-01-30 2018-01-23 4 Mazaltov Avi VBIV Option (Right to Buy Common Shares) A - Award D 4.19 100,000 100,000
2018-01-29 3 Kariv Tomer By Pontifax (China) IV Limited Partnership VBIV Common Stock I 2,907,105
2018-01-29 3 Kariv Tomer By Pontifax (Israel) IV Limited Partnership VBIV Common Stock I 3,427,055
2018-01-29 3 Kariv Tomer By Pontifax (Cayman) IV Limited Partnership VBIV Common Stock I 2,846,172
2018-01-29 3 Kariv Tomer By Pontifax (China) IV Limited Partnership VBIV Common Stock I 2,907,105
2018-01-29 3 Kariv Tomer By Pontifax (Israel) IV Limited Partnership VBIV Common Stock I 3,427,055
2018-01-29 3 Kariv Tomer By Pontifax (Cayman) IV Limited Partnership VBIV Common Stock I 2,846,172
2018-01-29 2018-01-23 4 Kariv Tomer VBIV Option (Right to Buy Common Shares) A - Award D 4.19 75,000 75,000
2018-01-26 2018-01-23 4 DeWilde Michel VBIV Option (Right to Buy Common Shares) A - Award D 4.19 75,000 75,000
2018-01-25 2018-01-23 4 GILLIS STEVEN VBIV Option (Right to Buy Common Shares) A - Award D 4.19 100,000 100,000
2018-01-25 2018-01-23 4 Logal Adam VBIV Option (Right to Buy Common Shares) A - Award D 4.19 75,000 75,000
2018-01-25 2018-01-23 4 Rubin Steven D VBIV Option (Right to Buy Common Shares) A - Award D 4.19 75,000 75,000
2018-01-25 2018-01-23 4 Diaz-Mitoma Francisco VBIV Option (Right to Buy Common Shares) A - Award D 4.26 100,000 100,000
2018-01-25 2018-01-23 4 Beattie Nell VBIV Option (Right to Buy Common Shares) A - Award D 4.19 100,000 100,000
2018-01-25 2018-01-23 4 Anderson David Evander VBIV Option (Right to Buy Common Shares) A - Award D 4.19 100,000 100,000
2018-01-25 2018-01-23 4 Buckley T. Adam VBIV Option (Right to Buy Common Shares) A - Award D 4.19 75,000 75,000
2018-01-25 2018-01-23 4 Requadt Scott VBIV Option (Right to Buy Common Shares) A - Award D 4.19 75,000 75,000
2018-01-25 2018-01-23 4 Baxter Jeff VBIV Option (Right to Buy Common Shares) A - Award D 4.19 150,000 150,000
2017-12-13 2017-12-12 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 3.8800 4,609 18 145,255
2017-12-13 2017-12-12 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 3.8900 5,391 21 140,646
2017-11-29 2017-11-28 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 4.7500 15,000 71 135,255
2017-11-09 3 Opko Health, Inc. VBIV Common Stock D 12,046,028
2017-11-09 3 Opko Health, Inc. VBIV Common Stock D 12,046,028
2017-11-01 2017-10-30 4 Opko Health, Inc. VBIV Common Stock P - Purchase D 3.0500 655,738 2,000 6,678,752
2017-10-31 3 Nussbaum Ran By Pontifax (Israel) IV Limited Partnership VBIV Common Shares, no par value per share I 3,427,055
2017-10-31 3 Nussbaum Ran By Pontifax (Cayman) IV Limited Partnership VBIV Common Shares, no par value per share I 2,846,172
2017-10-31 3 Nussbaum Ran By Pontifax (China) IV Limited Partnership VBIV Common Shares, no par value per share I 2,907,105
2017-10-31 3 Nussbaum Ran By Pontifax (Israel) IV Limited Partnership VBIV Common Shares, no par value per share I 3,427,055
2017-10-31 3 Nussbaum Ran By Pontifax (Cayman) IV Limited Partnership VBIV Common Shares, no par value per share I 2,846,172
2017-10-31 3 Nussbaum Ran By Pontifax (China) IV Limited Partnership VBIV Common Shares, no par value per share I 2,907,105
2017-10-31 2017-10-30 4 CHAWLA SAM VBIV Common Shares, no par value per share P - Purchase I 3.0500 3,100,000 9,455 9,345,725
2017-10-31 2017-10-30 4 GILLIS STEVEN VBIV Common Shares, no par value per share P - Purchase I 3.0500 300,000 915 3,026,057
2017-10-30 2017-10-26 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock P - Purchase I 3.0500 3,100,000 9,455 9,345,725
2017-08-22 2017-08-21 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share P - Purchase I 3.1700 3,000 10 3,000
2017-08-22 2017-08-21 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 3.2200 10,000 32 120,255
2017-08-14 2017-08-10 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 3.2800 10,000 33 110,255
2017-06-23 2017-06-22 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share A - Award D 12,500 264,339
2017-06-16 2017-06-14 4 DeWilde Michel VBIV Restricted Stock Units (RSUs) M - Exercise D -12,500 25,000
2017-06-16 2017-06-14 4 DeWilde Michel VBIV Common Shares, no par value per share M - Exercise D 12,500 25,000
2017-06-16 2017-06-14 4 Buckley T. Adam VBIV Restricted Stock Units (RSUs) M - Exercise D -4,687 9,374
2017-06-16 2017-06-14 4 Buckley T. Adam VBIV Common Shares, no par value per share M - Exercise D 4,687 44,063
2017-06-16 2017-06-14 4 Rubin Steven D VBIV Restricted Stock Units (RSUs) M - Exercise D -18,750 37,500
2017-06-16 2017-06-14 4 Rubin Steven D VBIV Common Shares, no par value per share M - Exercise D 18,750 37,500
2017-06-16 2017-06-14 4 GILLIS STEVEN VBIV Restricted Stock Units (RSUs) M - Exercise D -18,750 37,500
2017-06-16 2017-06-14 4 GILLIS STEVEN VBIV Common Shares, no par value per share M - Exercise D 18,750 46,916
2017-06-16 2017-06-14 4 CHAWLA SAM VBIV Restricted Stock Units (RSUs) M - Exercise D -12,500 25,000
2017-06-16 2017-06-14 4 CHAWLA SAM VBIV Common Shares, no par value per share M - Exercise D 12,500 25,000
2017-06-16 2017-06-14 4 Requadt Scott VBIV Restricted Stock Units (RSUs) M - Exercise D -12,500 25,000
2017-06-16 2017-06-14 4 Requadt Scott VBIV Common Shares, no par value per share M - Exercise D 12,500 25,000
2017-06-16 2017-06-14 4 Anderson David Evander VBIV Restricted Stock Units (RSUs) M - Exercise D -21,875 43,750
2017-06-16 2017-06-14 4 Anderson David Evander VBIV Common Shares, no par value per share M - Exercise D 21,875 88,740
2017-06-16 2017-06-14 4 Baxter Jeff VBIV Restricted Stock Units (RSUs) M - Exercise D -31,250 62,500
2017-06-16 2017-06-14 4 Baxter Jeff VBIV Common Shares, no par value per share M - Exercise D 31,250 100,255
2017-06-16 2017-06-14 4 Beattie Nell VBIV Restricted Stock Units (RSUs) M - Exercise D -6,250 12,500
2017-06-16 2017-06-14 4 Beattie Nell VBIV Common Shares, no par value per share M - Exercise D 6,250 12,500
2017-06-16 2017-06-14 4 Logal Adam VBIV Restricted Stock Units (RSUs) M - Exercise D -12,500 25,000
2017-06-16 2017-06-14 4 Logal Adam VBIV Common Shares, no par value per share M - Exercise D 12,500 25,000
2017-04-27 3 Baxter Jeff VBIV Common Shares, no par value per share D 138,010
2017-04-27 3 Baxter Jeff VBIV Common Shares, no par value per share D 138,010
2017-04-27 3 DeWilde Michel VBIV Common Shares, no par value per share D 25,000
2017-04-27 3 DeWilde Michel VBIV Common Shares, no par value per share D 25,000
2017-04-27 2017-04-18 4 Baxter Jeff VBIV Option (Right to Buy Common Shares) A - Award D 3.79 20,000 20,000
2017-04-27 2017-04-17 4 DeWilde Michel VBIV Option (Right to Buy Common Shares) A - Award D 3.79 12,500 12,500
2017-04-04 3 Anderson David Evander VBIV Common Shares, no par value per share D 133,730
2017-04-04 3 Anderson David Evander VBIV Common Shares, no par value per share D 133,730
2017-04-04 3 Beattie Nell VBIV Common Shares, no par value per share D 12,500
2017-04-04 3 Beattie Nell VBIV Common Shares, no par value per share D 12,500
2017-04-04 3 Requadt Scott VBIV Common Shares, no par value per share D 2,716,042
2017-04-04 3 Requadt Scott VBIV Common Shares, no par value per share I 5,394,584
2017-04-04 3 Requadt Scott VBIV Common Shares, no par value per share D 2,716,042
2017-04-04 3 Requadt Scott VBIV Common Shares, no par value per share I 5,394,584
2017-04-04 2017-04-03 4 Beattie Nell VBIV Option (Right to Buy Common Shares) A - Award D 3.79 20,000 20,000
2017-04-04 2017-03-31 4 Requadt Scott VBIV Option (Right to Buy Common Shares) A - Award D 3.79 12,500 12,500
2017-04-04 2017-03-31 4 Anderson David Evander VBIV Option (Right to Buy Common Shares) A - Award D 3.79 20,000 20,000
2017-03-31 3 Logal Adam VBIV Common Shares, no par value per share D 25,000
2017-03-31 3 Logal Adam VBIV Common Shares, no par value per share D 25,000
2017-03-31 3 CHAWLA SAM VBIV Common Shares, no par value per share D 6,590,843
2017-03-31 3 CHAWLA SAM VBIV Common Shares, no par value per share I 13,144,186
2017-03-31 3 CHAWLA SAM VBIV Common Shares, no par value per share I 13,144,186
2017-03-31 3 CHAWLA SAM VBIV Common Shares, no par value per share D 6,590,843
2017-03-31 3 Nascimento Egidio VBIV Common Shares, no par value per share D 5,936
2017-03-31 3 Nascimento Egidio VBIV Common Shares, no par value per share D 5,936
2017-03-31 3 Buckley T. Adam VBIV Common Shares, no par value per share D 78,752
2017-03-31 3 Buckley T. Adam VBIV Common Shares, no par value per share D 78,752
2017-03-31 3 Rubin Steven D VBIV Common Shares, no par value per share D 37,500
2017-03-31 3 Rubin Steven D VBIV Common Shares, no par value per share D 37,500
2017-03-31 3 GILLIS STEVEN VBIV Common Shares, no par value per share I 5,473,903
2017-03-31 3 GILLIS STEVEN VBIV Common Shares, no par value per share D 2,769,635
2017-03-31 3 GILLIS STEVEN VBIV Common Shares, no par value per share I 5,473,903
2017-03-31 3 GILLIS STEVEN VBIV Common Shares, no par value per share D 2,769,635
2017-03-31 3 Eckenswiller Catherine VBIV Common Shares, no par value per share D 0
2017-03-31 3 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share I 278,147
2017-03-31 3 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share I 278,147
2017-03-31 3 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share D 498,082
2017-03-31 3 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share D 498,082
2017-03-31 2017-03-29 4 Diaz-Mitoma Francisco VBIV Option (Right to Buy Common Shares) A - Award D 3.45 20,000 20,000
2017-03-31 2017-03-29 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share A - Award D 12,500 251,839
2017-03-31 2017-03-30 4 Rubin Steven D VBIV Option (Right to Buy Common Shares) A - Award D 3.79 12,500 12,500
2017-03-31 2017-03-29 4 GILLIS STEVEN VBIV Option (Right to Buy Common Shares) A - Award D 3.79 15,000 15,000
2017-03-31 2017-01-17 4 GILLIS STEVEN VBIV Option (Right to Buy Common Shares) M - Exercise D 2.50 2.5000 -6,377 -16 0
2017-03-31 2017-01-17 4 GILLIS STEVEN VBIV Common Shares, no par value per share M - Exercise D 2.5000 6,377 16 28,166
2017-03-31 2017-03-31 4 Eckenswiller Catherine VBIV Option (Right to Buy Common Shares) A - Award D 3.45 3,000 3,000
2017-03-31 2017-03-30 4 Nascimento Egidio VBIV Option (Right to Buy Common Shares) A - Award D 3.45 20,000 20,000
2017-03-31 2017-03-30 4 Buckley T. Adam VBIV Option (Right to Buy Common Shares) A - Award D 3.79 20,000 20,000
2017-03-31 2017-03-30 4 Logal Adam VBIV Option (Right to Buy Common Shares) A - Award D 3.79 12,500 12,500
2017-03-31 2017-03-30 4 CHAWLA SAM VBIV Option (Right to Buy Common Shares) A - Award D 3.79 12,500 12,500
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista